Image For Activity Cover
ORN Fall 2023 - Operationalizing a Definition of Precipitated Withdrawal and the Absorption, Distribution, Metabolism, and Elimination of Illicitly Manufactured Fentanyl
AVAILABLE ON-DEMAND
Available on-demand. Login or create an account to register to view the recording.
Description:
This webinar will discuss challenges of illicit fentanyl consumption. The data presented will discuss a recent operational definition of precipitated opioid withdrawal, drawn from an empirical study, and will introduce how the unique absorption, distribution, metabolization, and excretion of fentanyl may be contributing to fentanyl's unique profile of effects in patients.
Learning Objectives:
At the conclusion of the seminar learners will be able to:
  1. Learn about the peripheral distribution and excretion patterns of fentanyl
  2. Understand how fentanyl may be interacting in unique ways with buprenorphine 
  3. Learn the operational definition for differentiating precipitated from spontaneous opioid withdrawal
Claim Credits & Course Materials

How to claim your credits & download handouts for each webinar:

Under the "Course" tab (or "Content" tab):
  1. Complete the required course materials.
  2. Claim your credits by clicking the "Report Credit" or "Request Credit" button on the right above the course materials.
Speaker:
Kelly E. Dunn, Ph.D., MBA

Kelly E. Dunn, Ph.D., MBA is a Professor in the Behavioral Pharmacology Research Unit within the Department of Psychiatry and Behavioral Sciences in the Johns Hopkins University School of Medicine. Dr. Dunn has worked in the area of opioid use disorder treatment and withdrawal mitigation since 2005 and has served as the Principal Investigator on grants totaling more than $20 million from the National Institute on Drug Abuse. Dr. Dunn has also served in positions of leadership in the Substance Use Disorder (SUD) field, including incoming Editor-in-Chief of the journal Experimental and Clinical Psychopharmacology (ECP), President-elect and member of the Board of Directors for the College on the Problems of Drug Dependence, the 2021 President of the American Psychological Association's (APA) Division on Psychopharmacology and Substance Use, Chair of the Board of Convention Affairs for the APA annual convention, and Co-Editor at the Journal of Addiction Medicine. She is also the editor of the Oxford Handbook of Opioids and Opioid Use Disorder.


Summary
Availability: No future session
Expires on Dec 31, 2024
Cost: FREE
Credit Offered:
1 AMA PRA Category 1 Credit
1 AOA Category 1A Credit
Recommended
Powered By